Deferred Revenue
Boston Scientific Deferred Revenue increased by 2.9% to $359.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $328.00M to $359.00M. Over 4 years (FY 2020 to FY 2024), Deferred Revenue shows an upward trend with a 6.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.
Detailed definition
Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...
Peer comparison
High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.
deferred_revenue_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $283.00M | $296.00M | $276.00M | $279.00M | $279.00M | $278.00M | $289.00M | $290.00M | $295.00M | $301.00M | $311.00M | $314.00M | $316.00M | $328.00M | $329.00M | $335.00M | $349.00M | $359.00M |
| QoQ Change | — | +4.6% | -6.8% | +1.1% | +0.0% | -0.4% | +4.0% | +0.3% | +1.7% | +2.0% | +3.3% | +1.0% | +0.6% | +3.8% | +0.3% | +1.8% | +4.2% | +2.9% |
| YoY Change | — | — | — | — | -1.4% | -6.1% | +4.7% | +3.9% | +5.7% | +8.3% | +7.6% | +8.3% | +7.1% | +9.0% | +5.8% | +6.7% | +10.4% | +9.5% |
Deferred Revenue at Other Companies
Frequently Asked Questions
- What is Boston Scientific's deferred revenue?
- Boston Scientific (BSX) reported deferred revenue of $359.00M in Q3 2025.
- How has Boston Scientific's deferred revenue changed year-over-year?
- Boston Scientific's deferred revenue increased by 9.5% year-over-year, from $328.00M to $359.00M.
- What is the long-term trend for Boston Scientific's deferred revenue?
- Over 4 years (2020 to 2024), Boston Scientific's deferred revenue has grown at a 6.4% compound annual growth rate (CAGR), from $257.00M to $329.00M.
- What does deferred revenue mean?
- Money collected from customers for products or services that haven't been delivered yet but will be within a year.